Pharmacological Effects on Polysomnography and Multiple Sleep Latency Testing
| Course Id | 261802 |
| Course Name | Pharmacological Effects on Polysomnography and Multiple Sleep Latency Testing |
| Course Catagory | Sleep |
| Course Price | 25.11 |
| Course CEU | 2 |
Course Objectives
Upon successful completion of this module, you will be able to:
- Identify the major drug classes that suppress REM sleep and describe the neurochemical mechanisms underlying REM suppression.
- Recognize the characteristic PSG signatures produced by benzodiazepines, non-benzodiazepine hypnotics, antidepressants, stimulants, opioids, beta-blockers, and alcohol.
- Explain why SSRIs and SNRIs can produce REM sleep behavior disorder (RBD)-like phenomena and excess eye movements during REM.
- Determine which medications must be discontinued prior to MSLT and explain the rationale and recommended washout periods for each.
- Apply knowledge of drug-sleep interactions to flag pharmacologically confounded PSG and MSLT studies and communicate findings accurately in reports.
- Counsel clinical teams on medication management strategies to optimize the diagnostic validity of sleep studies.
- Differentiate between primary sleep disorders and drug-induced sleep architecture changes using PSG data.